热门资讯> 正文

Inventiva S.A报告9M结果

2025-11-22 05:05

Inventiva SA ADR(IVA) 0

Inventiva S.A (IVA): Revenues for the first nine months of 2025 amounted to €4.5 million, compared to none generated for the same period in 2024.
Cash and cash equivalents at €97.6 million, and €24.7 million in short-term deposits as of September 30, 2025.
Cash runway expected until the end of the first quarter of 2027.

More on Inventiva S.A

Inventiva S.A. (IVA) Analyst/Investor Day - Slideshow
Inventiva S.A. (IVA) Analyst/Investor Day Transcript
Inventiva announces $125M U.S. public offering of ADSs
MASH drug developers rise as FDA accepts lenient trial requirement
Seeking Alpha’s Quant Rating on Inventiva S.A

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。